The partnership makes Pearl’s industry leading AI solutions available to Curve’s 50,000 users in the US and Canada.
Pearl, the global leader in dental AI solutions, and Curve Dental, the leading cloud-based dental management software company, announced plans to integrate Pearl’s Second Opinion disease detection capabilities within Curve Dental’s all-in-one SuperHero practice management system. The Pearl-Curve partnership delivers the most robust range of FDA-cleared clinical AI capabilities to Curve’s 50,000 users across the United States and Canada.
Latest AI/NLP Technology Insights: ProcessUnity Acquires AI/NLP Technology from ISMS Solutions
“Our partnership with Curve expands Pearl’s commitment to elevating the standard of care in dentistry”
“The best dental technologies empower providers to better diagnose treatments and create a patient experience that increases treatment acceptance. Pearl’s AI does exactly those things,” said Jana Macon, Chief Operating Officer at Curve Dental. “We are thrilled to partner with Pearl because their technology will help us to deliver greater clinical utility and profitability to our customers.”
AI News: An Investment Into Artificial Intelligence as Daktela Buys Coworkers.ai
Pearl’s Second Opinion® is the only clinical AI software with regulatory clearance as a patient-facing radiologic aid to dentists for detection of multiple dental diseases. Curve users will be able to access the full range of Second Opinion® capabilities utilizing the images they take and store in Curve Image.
“Our partnership with Curve expands Pearl’s commitment to elevating the standard of care in dentistry,” said Ophir Tanz, Founder and CEO of Pearl. “Together with Curve, we’re increasing access to AI among Curve’s users and improving the quality of the AI-user experience with Pearl’s AI capabilities assimilated with one of the most highly user-rated practice management solutions in dentistry.”
Latest Aithority Insights : Got It AI Announces AutoFlows, a Breakthrough Autonomous Conversational AI
[To share your insights with us, please write to sghosh@martechseries.com]
Comments are closed.